Tru Independence LLC Alaunos Therapeutics, Inc. Transaction History

Tru Independence LLC

  • $334 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 19, 2020
SELL
$2.39 - $3.43 $510,771 - $733,032
-213,712 Closed
0 $0
Q2 2020

Aug 19, 2020
SELL
$2.2 - $3.71 $145,640 - $245,602
-66,200 Reduced 23.65%
213,712 $701,000
Q4 2019

May 19, 2020
BUY
$3.95 - $5.35 $1.11 Million - $1.5 Million
279,912 New
279,912 $686,000

Others Institutions Holding TCRT

# of Institutions
5
Shares Held
92.6K
Call Options Held
0
Put Options Held
0
View Full List

About Alaunos Therapeutics, Inc.

TCRT Quotes by TradingView
  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $424M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Tru Independence LLC Portfolio

Follow Tru Independence LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tru Independence LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email